Journal Mobile Options
Table of Contents
Vol. 40, No. 5, 2008
Issue release date: August 2008
Ophthalmic Res 2008;40:221–226

Retinoblastoma: From Disease to Discovery

Madhavan J. · Ganesh A. · Kumaramanickavel G.
aSN ONGCDepartment of Genetics and Molecular Biology, Vision Research Foundation, Sankara Nethralaya, Chennai, India; bDepartment of Ophthalmology, Sultan Qaboos University Hospital, Muscat, Oman

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Retinoblastoma has contributed much to the understanding of cancer. It provided the classic ‘two-hit model’ for oncogenesis and helped to identify the first tumor suppressor gene RB1. Thirty years since then, the search for additional events underlying disease progression continues. Phenotypic variations in retinoblastoma offer numerous clues to disease pathogenesis. Understanding their molecular biological basis will provide insight into mechanisms underlying tumor progression. These not fully understood genetic and stochastic events play a major role in uncontrolled retinal precursor cell proliferation. Comparative genomic hybridization and gene expression studies have facilitated probing of genes controlling basic events in cellular development, i.e. proliferation, differentiation and apoptosis. Research to determine the cell of origin that underlies the evolution of retinoblastoma can lead to understanding of the stochastic events underlying the genesis of this cancer, which currently remains unclear. In this review, we discuss the recent developments in retinoblastoma and describe how they are beginning to shape a new and revised picture of retinoblastoma pathogenesis and progression.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Knudson AG Jr: Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;168:820–823.

    External Resources

  2. Gallie BL, Ellsworth RM, Abramson DH, Phillips RA: Retinoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation? Br J Cancer 1982;45:513–521.
  3. Eagle RCJ, Shields JA, Donoso L, Milner RS: Malignant transformation of spontaneously regressed retinoblastoma, retinoma/retinocytoma variant. Ophthalmology 1989;96:1389–1395.
  4. Rychener RO: Retinoblastoma in the adult. Trans Am Ophthalmol Soc 1948;46:318–326.
  5. Shields JA, Shields CL: Retinoblastoma: clinical and pathologic features; in Shields JA, Shields CL (eds): Intraocular Tumors. A Text and Atlas. Philadelphia, Saunders, 1992, pp 305–332.
  6. Balmer A, Munier F, Gailloud C: Retinoma. Case studies. Ophthalmol Paediatr Genet 1991;12:131–137.
  7. Lueder GT, Heon E, Gallie BL: Retinoma associated with vitreous seeding. Am J Ophthalmol 1995;119:522–523.
  8. Gallie BL, Phillips RA, Ellsworth RM, Abramson DH: Significance of retinoma and phthisis bulbi for retinoblastoma. Ophthalmology 1982;89:1393–1399.
  9. DiCiommo D, Gallie BL, Bremner R: Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer. Semin Cancer Biol 2000;10:255–269.
  10. ZielinskiB, GratiasS, ToedtG, MendrzykF, Stange DE, Radlwimmer B, LohmannDR, Lichter P: Detection of chromosomal imbalances in retinoblastoma by matrix-based comparative genomic hybridization. Genes Chromosomes Cancer 2005;3:294–301.
  11. Lillington DM, Kingston JE, Coen PG, Price E, Hungerford J, Domizio P, Young BD, Onadim Z: Comparative genomic hybridization of 49 primary retinoblastoma tumors identifies chromosomal regions associated with histopathology, progression, and patient outcome. Genes Chromosomes Cancer 2003;36:121–128.
  12. Mairal A, Pinglier E, Gilbert E, Peter M, Validire P, Desjardins L, Doz F, Aurias A, Couturier J: Detection of chromosome imbalances in retinoblastoma by parallel karyotype and CGH analyses. Genes Chromosomes Cancer 2000;28:370–379.
  13. Herzog S, Lohmann DR, Buiting K, Schuler A, Horsthemke B, Rehder H, Rieder H: Marked differences in unilateral isolated retinoblastomas from young and older children studied by comparative genomic hybridization. Hum Genet 2001;2:98–104.

    External Resources

  14. Chen D, Gallie BL, Squire JA: Minimal regions of chromosomal imbalance in retinoblastoma detected by comparative genomic hybridization. Can Genet Cytogenet 2001;129:57–63.
  15. Bowles E, Corson TW, Bayani J, Squire JA, Wong N, Lai PBS, Gallie BL: Profiling genomic copy number changes in retinoblastoma beyond loss of RB1. Genes Chromosomes Cancer 2007;46:118–129.
  16. Corson TW, Huang A, Tsao MS, Gallie BL: KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers. Oncogene 2005;24:4741–4753.
  17. Madhavan J, Coral K, Mallikarjuna K, Corson TW, Amit N, Khetan V, George R, Biswas J, Gallie BL, Kumaramanickavel G: High expression of KIF14 in retinoblastoma: association with older age at diagnosis. Invest Ophthalmol Vis Sci 2007;48:4901–4906.
  18. Durand B, Raff M: A cell-intrinsic timer that operates during oligodendrocyte development. Bioessays2000;22:64–71.
  19. Durand B, Gao FB, Raff M: Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation. EMBO J 1997;16:306–317.
  20. Ohnuma S, Philpott A, Wang K, Holt CE, Harris WA: p27Xic1, a Cdk inhibitor, promotes the determination of glial cells in Xenopus retina. Cell 1999;99:499–510.
  21. Dyer MA, Cepko CL: P57kip2 regulates progenitor cell proliferation and amacrine interneuron development in the mouse retina. Development 2000;127:3593–3605.
  22. Chen D, Livne-bar I, Vanderluit JL, Slack RS, Agochiya M, Bremner R: Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma. Cancer Cell 2004;5:539–551.
  23. Laurie NA, Donovan SL, Shih CS, Zhang J, Mills N, Fuller C, Teunisse A, Lam S, Ramos Y, Mohan A, Johnson D, Wilson M, Galindo CR, Quarto M, Francoz S, Mendrysa SM, Guy RK, Marine JC, Jochemsen AG, Dyer MA: Inactivation of the p53 pathway in retinoblastoma. Nature 2006;444:61–66.
  24. Cepko CL, Austin CP, Yang X, Alexiades M, Ezzeddine D: Cell fate determination in the vertebrate retina. Proc Natl Acad Sci USA 1996;93:589–595.
  25. LaVail MM, Rapaport DH, Rakic P: Cytogenesis in the monkey retina. J Comp Neurol 1991;309:86–114.
  26. Stiemke MM, Hollyfield JG: Cell birthdays in Xenopus laevis retina. Differentiation 1995;58:189–193.
  27. Young RW: Cell differentiation in the retina of the mouse. Anat Rec 1985;212:199–205.
  28. Carter-Dawson LD, LaVail MM: Rods and cones in the mouse retina. 2. Autoradiographic analysis of cell generation using tritiated thymidine. J Comp Neurol 1979;188:263–272.
  29. Turner DL, Cepko CL: A common progenitor for neurons and glia persists in rat retina late in development. Nature 1987;328:131–136.
  30. Holt CE, Bertsch TW, Ellis HM, Harris WA: Cellular determination in the Xenopus retina is independent of lineage and birth date. Neuron 1988;1:15–26.
  31. Austin CP, Feldman DE, Ida JA, Cepko CL: Vertebrate retinal ganglion cells are selected from competent progenitors by the action of Notch. Development 1995;121:3637–3650.
  32. Belliveau MJ, Cepko CL: Extrinsic and intrinsic factors control the genesis of amacrine and cone cells in the rat retina. Development 1999;126:555–556.
  33. Belliveau MJ, Young TL, Cepko CL: Late retinal progenitor cells show intrinsic limitations in the production of cell types and the kinetics of opsin synthesis. J Neurosci 2000;20:2247–2254.
  34. Bremner R, Chen D, Pacal M, Livne-Bar I, Agochiya M: The RB protein family in retinal development and retinoblastoma: new insights from new mouse models. Dev Neurosci 2004;26:417–434.
  35. Dyer MA, Bremner R: The search for the retinoblastoma cell of origin. Nature 2005;5:91–100.
  36. Perentes E, Herbort CP, Rubinstein LJ, Herman MM, Uffer S, Donoso LA, Collins VP: Immunohistochemical characterization of human retinoblastomas in situ with multiple markers. Am J Ophthalmol 1987;103:647–658.
  37. Rodrigues MM, Wiggert B, Shields J, Donoso L, Bardenstein D, Katz N, Friendly D, Chader G: Retinoblastoma. Immunohistochemistry and cell differentiation. Ophthalmology 1987;94:378–387.
  38. Nork TM, Schwartz TL, Doshi HM, Millecchia LL: Retinoblastoma. Cell of origin. Arch Ophthalmol 1995;113:791–802.
  39. Madhavan J, Ganesh A, Roy J, Biswas J, Kumaramanickavel G: The relationship between tumor cell differentiation and age at diagnosis in retinoblastoma. J Pediatr Ophthalmol Strabismus 2008;45:22–25.
  40. Windle JJ, Albert DM, O’Brain JM, Marcus DM, Disteche CM, Bernards R, Mellon PL: Retinoblastoma in transgenic mice. Nature 1990;343:665–669.
  41. Howes KA, Lasudry JGH, Albert DM, Windle JJ: Photoreceptor cell tumor in transgenic mice. Invest Ophthalmol Vis Sci 1994;35:342–351.
  42. Al-Ubaidi MR, Font RL, Quiambao AB, Keener MJ, Liou GI, Overbeek PA, Boeher W: Bilateral retinal and brain tumors in transgenic mice expressing simian virus 40 large T antigen under control of human interphotoreceptor retinoid-binding protein promoter. J Cell Biol 1992;119:1681–1687.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50